trial · primary record
MK-4716
Malignant Neoplasm
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 250 |
| Primary completion | 2030-12-01 |
| Primary endpoint | Number of Participants Who Experience One or More Dose-Limiting Toxicities (DLT) |
| Registry ID | NCT07247110 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:14.417Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07247110
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.